We are live on
!
Find out more
MIM
Monashee Investment Management Portfolio holdings
AUM
$59.6M
1-Year Est. Return
181.61%
This Fund
S&P 500
This Quarter
Est. Return
+37.77%
1 Year Est. Return
+181.61%
3 Year Est. Return
+519.89%
5 Year Est. Return
+603.37%
10 Year Est. Return
+6,669.07%
AUM
$201M
AUM Growth
-$75.4M
(-27%)
Cap. Flow
-$3.6M
Cap. Flow
% of AUM
-1.79%
Top 10 Holdings %
Top 10 Hldgs %
37.44%
Holding
107
New
50
Increased
2
Reduced
6
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIGR
Figure Technology Solutions
FIGR
|
+$7.77M |
| 2 |
AMBQ
Ambiq Micro
AMBQ
|
+$7.29M |
| 3 |
NTSK
Netskope Inc
NTSK
|
+$7.14M |
| 4 |
WYFI
WhiteFiber Inc
WYFI
|
+$6.94M |
| 5 |
Corebridge Financial
CRBG
|
+$6.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$15.6M |
| 2 |
Core Scientific
CORZ
|
+$11.9M |
| 3 |
Kratos Defense & Security Solutions
KTOS
|
+$11.6M |
| 4 |
Solid Biosciences
SLDB
|
+$10.5M |
| 5 |
GLXY
Galaxy Digital Inc
GLXY
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.36% |
| 2 | Technology | 20.19% |
| 3 | Financials | 19.53% |
| 4 | Industrials | 9.42% |
| 5 | Communication Services | 7.99% |
Similar funds
ICM
AP
GC
CPM
WWP
CZI
CT
GCS
Monashee Investment Management's Q3 2025 Portfolio in Review
As of Q3 2025, Monashee Investment Management held 107 positions worth $201M, down 27% from $276M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Monashee Investment Management's Q3 2025 filing shows 50 new, 2 increased, 6 reduced and 46 closed positions. Its largest new stake was Figure Technology Solutions: 200,000 shares worth $7.27M. The largest sale was Eli Lilly, an estimated $15.6M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Financials.
- Monashee Investment Management's largest Q3 2025 buy was Figure Technology Solutions: 200,000 shares worth $7.27M.
- Monashee Investment Management added most to Compass Therapeutics in Q3 2025, an estimated $3.43M increase.
- Monashee Investment Management's biggest Q3 2025 reduction was Structure Therapeutics, cutting an estimated $4.58M.
- Monashee Investment Management fully exited Eli Lilly in Q3 2025, selling an estimated $15.6M.
- Monashee Investment Management's ten largest holdings make up 37% of its $201M portfolio in Q3 2025.
- Monashee Investment Management opened 50 new positions and closed 46 in Q3 2025.
- Monashee Investment Management's portfolio value fell 27% quarter-over-quarter to $201M.
Based on Monashee Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.